SCHEMBL6010417

SCHEMBL6010417

CCCn1cc(C)c2c(=O)[nH]c(-c3ccc(OCC)c(S(=O)(=O)N4CCOCC4)c3)nc21

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
HTT P42858 1/20 0.48
PDE5A O76074 9/20 0.46
PDE1A P54750 1/20 0.46
PDE1B Q01064 1/20 0.46
PDE1C Q14123 1/20 0.46
TSHR P16473 2/20 0.45
CNR1 P21554 4/20 0.44
CNR2 P34972 4/20 0.44
SYK P43405 1/20 0.41
BRD4 O60885 1/20 0.40
BRD2 P25440 1/20 0.40
BRD3 Q15059 1/20 0.40
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3386364 0.90 PDE5A (0.48) PDE5APDE1APDE1BPDE1C
SCHEMBL3023423 0.86 PDE5A (0.63) PDE5APDE1APDE1BPDE1CCA12
SCHEMBL3386997 0.86 PDE5A (0.49) ALDH1A1SMN1; SMN2PDE5ATSHRBRD4
SCHEMBL3384950 0.83 PDE5A (0.41) ALDH1A1PDE5APDE1APDE1BPDE1C
SCHEMBL3031282 0.79 PDE5A (0.66) PDE5APDE1APDE1BPDE1C
SCHEMBL3012495 0.78 PDE5A (0.74) PDE5APDE1APDE1BPDE1C
SCHEMBL3023508 0.77 PDE5A (0.64) PDE5APDE1APDE1BPDE1CCA12
Tunodafil SCHEMBL3018511 0.77 PDE5A (0.65) PDE5APDE1APDE1BPDE1C
SCHEMBL3029660 0.76 PDE5A (0.64) ALDH1A1PDE5APDE1APDE1BPDE1C
SCHEMBL3383025 0.76 PDE5A (0.36) PDE5APDE1APDE1BPDE1CPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060173025-A1 2-Substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole [2,3-d]pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. (CN) 2006-08-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173025-A1 2-Substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole [2,3-d]pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof PDE5A, PDE3B, PDE2A ALDH1A1 1203/4885SMN1; SMN2 3347/4885HTT 4762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.